Document is current
Any future updates will be listed below
-
Authors
Zhao, Dan http://orcid.org/0000-0001-7066-9058
Li, Haiqing
Mambetsariev, Isa
Mirzapoiazova, Tamara
Chen, Chen
Fricke, Jeremy
Wheeler, Deric
Arvanitis, Leonidas
Pillai, Raju
Afkhami, Michelle
Chen, Bihong T.
Sattler, Martin
Erhunmwunsee, Loretta
Massarelli, Erminia
Kulkarni, Prakash
Amini, Arya
Armstrong, Brian
Salgia, Ravi http://orcid.org/0000-0001-9643-7626
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA033572, U54CA209978)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 4 June 2024
First Online: 19 June 2024
Competing interests
: The authors declare that they have no competing interests relevant to this work. D.Z. has clinical trial contract with Mirati, TriSalus and CARsgen and a member of advisory board for Affini-T.
